Skip to Main Content

Paper Details

Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens.
Int J Cancer
8
2022
AGAP1, BARD1, Bevacizumab, Cancer, Germline, PRUNE2, Patients, SNP, SNPs, advanced cancers, advanced colorectal and ovarian cancer, bevacizumab, cancer, colorectal and ovarian cancer, patient, patients, prognostic genes, rs16852804, rs3795897, rs680949, single nucleotide polymorphisms, tumor, tumor suppressor genes
Author NameAffiliation
Wei XuPrincess Margaret Cancer Centre, University Health Network
Wei XuDalla Lana School of Public Health, University of Toronto
Osvaldo Espin-GarciaPrincess Margaret Cancer Centre, University Health Network
Osvaldo Espin-GarciaDalla Lana School of Public Health, University of Toronto
Mark J RatainUniversity of Chicago Comprehensive Cancer Center
Geoffrey LiuPrincess Margaret Cancer Centre, University Health Network and University of Toronto
Kouros OwzarDuke Cancer Institute, Duke University Medical Center
Kouros OwzarDuke University Medical Center
Dan-Yu LinUniversity of North Carolina at Chapel Hill
  • 1 - 9

Datasets

Release 1.2